Aldeyra Therapeutics ALDX
NASDAQ ALDX
$0.67 -0.07 (-9.42%)
As of: Oct 21, 2026 · 3:28 PM EDT

Aldeyra Therapeutics (ALDX) Notes Payables (2013 - 2014)

Updated

Aldeyra Therapeutics (ALDX) reported Notes Payables of $155,097 for Q1 2014, up 82.5% from the prior quarter.

Analysis

Aldeyra Therapeutics (ALDX) Notes Payables (2013 - 2014) Analysis & Trends

At the end of FY2013, Aldeyra Therapeutics posted Notes Payables of $85,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.85 Bn 1,106.43 Bn 19.71 Bn
2 Johnson & Johnson 618.85 Bn 537.37 Bn 17.26 Bn
3 AbbVie 503.03 Bn 476.14 Bn 12.70 Bn
4 Merck 368.52 Bn 322.90 Bn 12.21 Bn
5 Novartis Ag 298.19 Bn 262.18 Bn 11.24 Bn
6 Astrazeneca 261.33 Bn 235.02 Bn 12.86 Bn
7 Amgen 237.14 Bn 192.53 Bn 7.24 Bn
8 Gilead Sciences 191.35 Bn 165.54 Bn 6.22 Bn
9 Pfizer 169.80 Bn 116.45 Bn 10.94 Bn
10 Aldeyra Therapeutics 40.05 Mn -215.38 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2014 155,097.00
Dec 31, 2013 85,000.00
API Access

Aldeyra Therapeutics Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=ALDX&period=max&api_key=YOUR_API_KEY